Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-21

Clinical Trial Update: Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial assessing the combined use of bevacizumab and mitomycin C during Ahmed valve revision in children with recurrent pediatric glauco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • Mitomycin-C (mitomycin C)

Snippet

Sponsor: Benha University | Conditions: Pediatric Glaucoma | EARLY_Phase 1 | Status: COMPLETED